AngioDynamics Inc (ANGO.OQ)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|56||2014||Independent Chairman of the Board|
|53||2016||President, Chief Executive Officer, Director|
|44||2017||Chief Financial Officer, Executive Vice President, IR Contact Officer|
|45||2017||Senior Vice President and General Manager, Peripheral Vascular|
|43||2016||Senior Vice President of Human Resources|
- BRIEF-AngioDynamics Q3 Earnings Per Share $0.37
- BRIEF-Angiodynamics Receives FDA Expedited Access Pathway Designation For Nanoknife System For Treatment Of Stage III Pancreatic Cancer
- BRIEF-AngioDynamics Says U.S. Tax Reform To Have Impact Of $0.02- $0.04 On Non-GAAP Adjusted EPS In FY 2018
- BRIEF-AngioDynamics Q2 GAAP Earnings Per Share $0.01